Effectiveness of Netarsudil versus Brimonidine in Eyes already Being Treated with Glaucoma Medications at a Single Academic Tertiary Care Practice: A Comparative Study

ABSTRACT: Background: Rho kinase inhibitors, such as netarsudil, are a relatively new class of medications recently introduced into the market for the treatment of glaucoma, the leading cause of irreversible blindness in the world. Previous clinical trials have studied netarsudil's efficacy wh...

Full description

Bibliographic Details
Main Authors: Alex T. Pham, BS, Chris Bradley, PhD, Corinne Casey, OD, Henry D. Jampel, MD, Pradeep Y. Ramulu, MD, PhD, Jithin Yohannan, MD, MPH
Format: Article
Language:English
Published: Elsevier 2023-01-01
Series:Current Therapeutic Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0011393X22000285